Skip to main content

MoneyWorks4Me

Alembic Pharmaceuticals informs about press release

18 Dec 2025 Evaluate

Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Travoprost Ophthalmic Solution USP, 0.004% (Ionic Buffered Solution). Enclosed press release of the same.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1838.00
Dr. Reddys Labs. 1354.65
Cipla 1373.90
Lupin 2011.60
Zydus Lifesciences 1239.10
View more..